Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy-Reference-Cited by-同舟云学术

Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy

Published:2000-12 Issue:18 Volume:36 Page:2360-2367
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Limat S,Woronoff-Lemsi M.-C,Milpied N,Chartrin I,Ifrah N,Deconinck E,Gressin R,Colombat P,Cahn J.-Y,Arveux P

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas;Hartmann;Ann. Intern. Med.,1997

2. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy;Weaver;Blood,1995

3. Factors that influence collection and engraftment of autologous peripheral blood stem cells;Bensinger;J. Clin. Oncol.,1995

4. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies;Faucher;J. Hematother.,1996

5. Pediatric experience with autologous peripheral blood progenitor cell transplantation influence of CD34+ cell dose in engraftment kinetics;Diaz;Bone Marrow Transplant,1996

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;Transfusion and Apheresis Science;2024-10

2. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers;The European Research Journal;2023-11-04

3. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;2023-08-07

4. Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma;Leukemia & Lymphoma;2019-07-18

5. Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors;Biology of Blood and Marrow Transplantation;2018-07